Insulin Delivery Devices-EMEA Market Status and Trend Report 2013-2023
Report Summary
Insulin Delivery Devices-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Insulin Delivery Devices industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Insulin Delivery Devices 2013-2017, and development forecast 2018-2023
Main market players of Insulin Delivery Devices in EMEA, with company and product introduction, position in the Insulin Delivery Devices market
Market status and development trend of Insulin Delivery Devices by types and applications
Cost and profit status of Insulin Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the EMEA Insulin Delivery Devices market as:
EMEA Insulin Delivery Devices Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Insulin Delivery Devices Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Insulin Pens (Reusable, Disposable)
Insulin Pumps (External/Tethered, Patch)
Pen Needles (Standard, Safety)
Insulin Syringes
EMEA Insulin Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Patients/Homecare
Hospitals & Clinics
EMEA Insulin Delivery Devices Market: Players Segment Analysis (Company and Product introduction, Insulin Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Medtronic, Inc.
Becton
F. Hoffmann-La Roche
Abbott Laboratories
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Becton Dickinson
Insulet
B. Braun Melsungen AG
Animas Corporation
Ypsomed Holdings AG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Insulin Delivery Devices-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Insulin Delivery Devices industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Insulin Delivery Devices 2013-2017, and development forecast 2018-2023
Main market players of Insulin Delivery Devices in EMEA, with company and product introduction, position in the Insulin Delivery Devices market
Market status and development trend of Insulin Delivery Devices by types and applications
Cost and profit status of Insulin Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the EMEA Insulin Delivery Devices market as:
EMEA Insulin Delivery Devices Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Insulin Delivery Devices Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Insulin Pens (Reusable, Disposable)
Insulin Pumps (External/Tethered, Patch)
Pen Needles (Standard, Safety)
Insulin Syringes
EMEA Insulin Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Patients/Homecare
Hospitals & Clinics
EMEA Insulin Delivery Devices Market: Players Segment Analysis (Company and Product introduction, Insulin Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Medtronic, Inc.
Becton
F. Hoffmann-La Roche
Abbott Laboratories
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Becton Dickinson
Insulet
B. Braun Melsungen AG
Animas Corporation
Ypsomed Holdings AG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF INSULIN DELIVERY DEVICES
1.1 Definition of Insulin Delivery Devices in This Report
1.2 Commercial Types of Insulin Delivery Devices
1.2.1 Insulin Pens (Reusable, Disposable)
1.2.2 Insulin Pumps (External/Tethered, Patch)
1.2.3 Pen Needles (Standard, Safety)
1.2.4 Insulin Syringes
1.3 Downstream Application of Insulin Delivery Devices
1.3.1 Patients/Homecare
1.3.2 Hospitals & Clinics
1.4 Development History of Insulin Delivery Devices
1.5 Market Status and Trend of Insulin Delivery Devices 2013-2023
1.5.1 EMEA Insulin Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Insulin Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Insulin Delivery Devices in EMEA 2013-2017
2.2 Consumption Market of Insulin Delivery Devices in EMEA by Regions
2.2.1 Consumption Volume of Insulin Delivery Devices in EMEA by Regions
2.2.2 Revenue of Insulin Delivery Devices in EMEA by Regions
2.3 Market Analysis of Insulin Delivery Devices in EMEA by Regions
2.3.1 Market Analysis of Insulin Delivery Devices in Europe 2013-2017
2.3.2 Market Analysis of Insulin Delivery Devices in Middle East 2013-2017
2.3.3 Market Analysis of Insulin Delivery Devices in Africa 2013-2017
2.4 Market Development Forecast of Insulin Delivery Devices in EMEA 2018-2023
2.4.1 Market Development Forecast of Insulin Delivery Devices in EMEA 2018-2023
2.4.2 Market Development Forecast of Insulin Delivery Devices by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Insulin Delivery Devices in EMEA by Types
3.1.2 Revenue of Insulin Delivery Devices in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Insulin Delivery Devices in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Insulin Delivery Devices in EMEA by Downstream Industry
4.2 Demand Volume of Insulin Delivery Devices by Downstream Industry in Major Countries
4.2.1 Demand Volume of Insulin Delivery Devices by Downstream Industry in Europe
4.2.2 Demand Volume of Insulin Delivery Devices by Downstream Industry in Middle East
4.2.3 Demand Volume of Insulin Delivery Devices by Downstream Industry in Africa
4.3 Market Forecast of Insulin Delivery Devices in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF INSULIN DELIVERY DEVICES
5.1 EMEA Economy Situation and Trend Overview
5.2 Insulin Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 6 INSULIN DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Insulin Delivery Devices in EMEA by Major Players
6.2 Revenue of Insulin Delivery Devices in EMEA by Major Players
6.3 Basic Information of Insulin Delivery Devices by Major Players
6.3.1 Headquarters Location and Established Time of Insulin Delivery Devices Major Players
6.3.2 Employees and Revenue Level of Insulin Delivery Devices Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 INSULIN DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Medtronic, Inc.
7.1.1 Company profile
7.1.2 Representative Insulin Delivery Devices Product
7.1.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
7.2 Becton
7.2.1 Company profile
7.2.2 Representative Insulin Delivery Devices Product
7.2.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Becton
7.3 F. Hoffmann-La Roche
7.3.1 Company profile
7.3.2 Representative Insulin Delivery Devices Product
7.3.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
7.4 Abbott Laboratories
7.4.1 Company profile
7.4.2 Representative Insulin Delivery Devices Product
7.4.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.5 Novo Nordisk A/S
7.5.1 Company profile
7.5.2 Representative Insulin Delivery Devices Product
7.5.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
7.6 Eli Lilly and Company
7.6.1 Company profile
7.6.2 Representative Insulin Delivery Devices Product
7.6.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.7 Sanofi
7.7.1 Company profile
7.7.2 Representative Insulin Delivery Devices Product
7.7.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Sanofi
7.8 Becton Dickinson
7.8.1 Company profile
7.8.2 Representative Insulin Delivery Devices Product
7.8.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Becton Dickinson
7.9 Insulet
7.9.1 Company profile
7.9.2 Representative Insulin Delivery Devices Product
7.9.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Insulet
7.10 B. Braun Melsungen AG
7.10.1 Company profile
7.10.2 Representative Insulin Delivery Devices Product
7.10.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG
7.11 Animas Corporation
7.11.1 Company profile
7.11.2 Representative Insulin Delivery Devices Product
7.11.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Animas Corporation
7.12 Ypsomed Holdings AG
7.12.1 Company profile
7.12.2 Representative Insulin Delivery Devices Product
7.12.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Ypsomed Holdings AG
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INSULIN DELIVERY DEVICES
8.1 Industry Chain of Insulin Delivery Devices
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF INSULIN DELIVERY DEVICES
9.1 Cost Structure Analysis of Insulin Delivery Devices
9.2 Raw Materials Cost Analysis of Insulin Delivery Devices
9.3 Labor Cost Analysis of Insulin Delivery Devices
9.4 Manufacturing Expenses Analysis of Insulin Delivery Devices
CHAPTER 10 MARKETING STATUS ANALYSIS OF INSULIN DELIVERY DEVICES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Insulin Delivery Devices in This Report
1.2 Commercial Types of Insulin Delivery Devices
1.2.1 Insulin Pens (Reusable, Disposable)
1.2.2 Insulin Pumps (External/Tethered, Patch)
1.2.3 Pen Needles (Standard, Safety)
1.2.4 Insulin Syringes
1.3 Downstream Application of Insulin Delivery Devices
1.3.1 Patients/Homecare
1.3.2 Hospitals & Clinics
1.4 Development History of Insulin Delivery Devices
1.5 Market Status and Trend of Insulin Delivery Devices 2013-2023
1.5.1 EMEA Insulin Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Insulin Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Insulin Delivery Devices in EMEA 2013-2017
2.2 Consumption Market of Insulin Delivery Devices in EMEA by Regions
2.2.1 Consumption Volume of Insulin Delivery Devices in EMEA by Regions
2.2.2 Revenue of Insulin Delivery Devices in EMEA by Regions
2.3 Market Analysis of Insulin Delivery Devices in EMEA by Regions
2.3.1 Market Analysis of Insulin Delivery Devices in Europe 2013-2017
2.3.2 Market Analysis of Insulin Delivery Devices in Middle East 2013-2017
2.3.3 Market Analysis of Insulin Delivery Devices in Africa 2013-2017
2.4 Market Development Forecast of Insulin Delivery Devices in EMEA 2018-2023
2.4.1 Market Development Forecast of Insulin Delivery Devices in EMEA 2018-2023
2.4.2 Market Development Forecast of Insulin Delivery Devices by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Insulin Delivery Devices in EMEA by Types
3.1.2 Revenue of Insulin Delivery Devices in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Insulin Delivery Devices in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Insulin Delivery Devices in EMEA by Downstream Industry
4.2 Demand Volume of Insulin Delivery Devices by Downstream Industry in Major Countries
4.2.1 Demand Volume of Insulin Delivery Devices by Downstream Industry in Europe
4.2.2 Demand Volume of Insulin Delivery Devices by Downstream Industry in Middle East
4.2.3 Demand Volume of Insulin Delivery Devices by Downstream Industry in Africa
4.3 Market Forecast of Insulin Delivery Devices in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF INSULIN DELIVERY DEVICES
5.1 EMEA Economy Situation and Trend Overview
5.2 Insulin Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 6 INSULIN DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Insulin Delivery Devices in EMEA by Major Players
6.2 Revenue of Insulin Delivery Devices in EMEA by Major Players
6.3 Basic Information of Insulin Delivery Devices by Major Players
6.3.1 Headquarters Location and Established Time of Insulin Delivery Devices Major Players
6.3.2 Employees and Revenue Level of Insulin Delivery Devices Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 INSULIN DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Medtronic, Inc.
7.1.1 Company profile
7.1.2 Representative Insulin Delivery Devices Product
7.1.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
7.2 Becton
7.2.1 Company profile
7.2.2 Representative Insulin Delivery Devices Product
7.2.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Becton
7.3 F. Hoffmann-La Roche
7.3.1 Company profile
7.3.2 Representative Insulin Delivery Devices Product
7.3.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
7.4 Abbott Laboratories
7.4.1 Company profile
7.4.2 Representative Insulin Delivery Devices Product
7.4.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.5 Novo Nordisk A/S
7.5.1 Company profile
7.5.2 Representative Insulin Delivery Devices Product
7.5.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
7.6 Eli Lilly and Company
7.6.1 Company profile
7.6.2 Representative Insulin Delivery Devices Product
7.6.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.7 Sanofi
7.7.1 Company profile
7.7.2 Representative Insulin Delivery Devices Product
7.7.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Sanofi
7.8 Becton Dickinson
7.8.1 Company profile
7.8.2 Representative Insulin Delivery Devices Product
7.8.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Becton Dickinson
7.9 Insulet
7.9.1 Company profile
7.9.2 Representative Insulin Delivery Devices Product
7.9.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Insulet
7.10 B. Braun Melsungen AG
7.10.1 Company profile
7.10.2 Representative Insulin Delivery Devices Product
7.10.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG
7.11 Animas Corporation
7.11.1 Company profile
7.11.2 Representative Insulin Delivery Devices Product
7.11.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Animas Corporation
7.12 Ypsomed Holdings AG
7.12.1 Company profile
7.12.2 Representative Insulin Delivery Devices Product
7.12.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Ypsomed Holdings AG
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INSULIN DELIVERY DEVICES
8.1 Industry Chain of Insulin Delivery Devices
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF INSULIN DELIVERY DEVICES
9.1 Cost Structure Analysis of Insulin Delivery Devices
9.2 Raw Materials Cost Analysis of Insulin Delivery Devices
9.3 Labor Cost Analysis of Insulin Delivery Devices
9.4 Manufacturing Expenses Analysis of Insulin Delivery Devices
CHAPTER 10 MARKETING STATUS ANALYSIS OF INSULIN DELIVERY DEVICES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
